AEON Valuation

Aeon Biopharma Inc (AEON) has a current Price-to-Book (P/B) ratio of -0.48. Compared to its 3-year average P/B ratio of -1.76 , the current P/B ratio is approximately -72.67% higher. Relative to its 5-year average P/B ratio of -2.51, the current P/B ratio is about -80.78% higher. Aeon Biopharma Inc (AEON) has a Forward Free Cash Flow (FCF) yield of approximately -135.85%. Compared to its 3-year average FCF yield of -237.41%, the current FCF yield is approximately -42.78% lower. Relative to its 5-year average FCF yield of -237.41% , the current FCF yield is about -42.78% lower.